COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION (CTSH): what the price requires

The current priced-in claim for COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION (CTSH) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/CTSH

Headline

FieldValue
TickerCTSH
CompanyCOGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
Current price$44.05/sh
CompositionConsulting and technology services 64% / Outsourcing services 36%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed4.9%
Operating margin today15.9%
Margin compression implied-11.0pp
Multiple paid6x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 9.2% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range

ReferenceValue
vs own history-1.33σ
cohort percentile (of 177 peers)3
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.77x5justifies
Earnings0.84x5justifies
Relative0.21x3justifies
Growth0.84x4justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.8%); the inversion above states its own rate.

Per-Model Detail (n=17)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$139.650.32xyesFCF base $2.6B, growth 7% (input: historical growth), terminal g 4.0%, WACC 8.8%, 6yr projection
DCF Exit MultipleGrowth$73.700.60xyesExit EV/EBITDA: 4.0x / 5.2x / 7.2x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$132.580.33xyesP/E 24.77x (blended: static sector reference 35x + trailing (TTM) 9x), scenarios: 20.7x / 24.8x / 28.9x (bear / base = reference held flat / bull), EV/EBITDA 17.09x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$18.232.42xyesStage 1: -3% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$50.520.87xyesBV/sh $31.59, ROE (TTM) 14.8%, ke 9.3%
Two-Stage Excess ReturnAsset$63.150.70xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$41.051.07xyesRev $21.4B, growth 7% (input: historical growth; tapered), Terminal P/S: 0.8x / 1.0x / 1.1x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$67.950.65xyesNormalized EBIT (5y avg op income, one-time charges added back) $3.06B × (1−21%) / WACC 8.8% → EPV (no growth)
Residual IncomeAsset$64.880.68xyesBV $31.59 + 5yr PV of (ROE (TTM) 14.8% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$57.240.77xyes√(22.5 × EPS $4.61 × BVPS $31.59) — Graham's conservative floor
EV/EBITDA RelativeRelative$207.050.21xyesEBITDA $3.93B × sector EV/EBITDA 25.0x
FCF YieldEarnings$56.840.77xyesFCF $2470.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$52.650.84xyesSBC-adj FCF $2.29B (FCF $2.47B − SBC $0.18B) capitalized at Kₑ
Ben Graham FormulaEarnings$12.043.66xyesEPS $4.61 × (8.5 + 2×-2.7%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$16.282.71xyesBV $31.59 × (ROIC 4.5% / WACC 8.8%)
P/Sales SectorRelative$359.010.12xyesRevenue $21.41B × sector P/S 8.0x
PEG Fair ValueRelative——no—
Earnings YieldEarnings$49.840.88xyesEPS $4.61 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net cash$927.0m
Net debt / NOPAT (after-tax)-0.35x (net cash)
Net debt / operating income (pre-tax)-0.27x (net cash)
Interest coverage93.9x
Share count CAGR (buyback)-2.4%
Burning cashno

Bullet Takeaways

At $43.68 (as of June 27, 2026) the stock trades at roughly 6x operating income, and every valuation family lands above the price. The blended methods anchor near $86, so on standard measures the market is pricing Cognizant well below where its earnings and assets sit.

The balance sheet is pristine: about $927 million of net cash and interest covered more than 100 times, leaving full flexibility for buybacks, dividends, and deals. This is a value-and-asset-supported name, not a growth bet.

Q1 2026 was solid: revenue up 5.8% to $5.41 billion, bookings of $29.6 billion at a 1.4 book-to-bill, seven large deals signed, and raised 2026 margin guidance to 16.0% to 16.2%. The discount exists because the market fears AI will erode demand for IT services.

Bull Case

Lead with how far the price sits below the methods, because that gap is the entire bull case. At $43.68 Cognizant trades around 6x operating income, and the valuation X-ray is unusual: every family, asset value, earnings power, peer multiples, and forward growth, lands above the price. The blended methods anchor near $86, roughly double the quote, which means the stock is priced as though the business is in decline when the results say otherwise. A company earning a 15.8% operating margin, carrying net cash, and growing the top line should not trade at a multiple normally reserved for melting-ice-cube businesses. The market has decided to underwrite a worst case, and the methods say it has overdone it.

The operating evidence does not support the pessimism. Q1 2026 revenue rose 5.8% to $5.41 billion, in the upper half of guidance, with bookings reaching $29.6 billion at a 1.4 book-to-bill ratio, the kind of forward coverage that signals demand rather than erosion. Cognizant signed seven large deals in the quarter and delivered more than 70% growth in large-deal total contract value year over year, with Financial Services leading. Management reaffirmed full-year revenue growth guidance of 4% to 6.5%. A business losing to AI does not book deals faster than it bills them.

The capital position turns the discount into an opportunity. Cognizant holds about $927 million of net cash against only $590 million of gross debt, with interest covered more than 100 times, so it can buy back stock aggressively at a 6x multiple, pay its dividend, and still fund acquisitions and AI investment. It is leaning into the shift rather than away from it: the AI builder strategy, deep industry expertise, and a scaled partnership ecosystem are aimed at helping clients convert AI spending into outcomes, and the new Project Leap program targets $200 to $300 million of 2026 savings that lifted margin guidance to 16.0% to 16.2%. The bull case is that Cognizant is a profitable, cash-rich, still-growing services leader trading at a distressed multiple on an AI fear that its own bookings contradict, and the methods near $86 mark how much room there is if sentiment normalizes.

Bear Case

The disruption thesis names specific competitors, and it is the reason the multiple is where it is. Cognizant competes against a long list of larger or faster rivals, including Accenture, Capgemini, CGI, Deloitte Digital, DXC Technology, EPAM Systems, Genpact, HCL Technologies, IBM Consulting, Infosys Technologies, Tata Consultancy Services, and Wipro, plus numerous smaller local players with established relationships in their markets (FY2025 10-K, accession 0001058290-26-000008). In a normal cycle that is a competitive but stable industry. The new variable is generative AI, which threatens the core economics of labor-arbitrage IT services: if AI tools let clients do more with fewer outsourced engineers, the headcount-linked revenue model that built Cognizant compresses. Accenture and the Indian majors are racing to reprice their offerings around AI, and the company that moves slowest loses share. The market is pricing Cognizant as the one most exposed to that squeeze.

The financial structure makes the fear concrete. Cognizant sells consulting and technology services for 64% of revenue and outsourcing for 36%, both of which are people-heavy and partly priced on effort. The Project Leap restructuring, while framed as savings, is expected to incur $230 to $320 million of costs largely in 2026, mostly severance and personnel charges, which is the company acknowledging it must cut headcount to defend margin. Cutting people to hold profitability is a defensive posture, not a growth one, and it signals that organic pricing power is under pressure even as bookings look healthy. Bookings can also be backloaded or lower-margin AI-transition work that does not convert to the same revenue the legacy model produced.

The valuation, cheap as it looks, can stay cheap if the disruption is structural rather than cyclical. The methods say the stock is worth near $86, but a multiple of 6x operating income is the market's verdict that future earnings will be lower than today's, and value traps are exactly the stocks where every static method screams cheap while the business slowly erodes. Analyst sentiment captures the standoff: the consensus is a Hold, with Morgan Stanley cutting its target to $44, right at the current price, on AI concerns, even as others stay constructive. The bear case is not that Cognizant is failing today; it is that the IT-services model faces a genuine technology shift, the company is already restructuring to defend margin, and a low multiple is not protection if the earnings base is the thing being disrupted.

Valuation

Invert the price first. At $43.68 the market pays only about 6x company-wide operating income, and the solve runs below the model floor: the price implies an operating margin of just 4.9% sustained, against the 15.8% the business actually earns. In other words, the price embeds a roughly two-thirds collapse in profitability that has not happened. That is why the priced-in assumption, while labeled within range, is really the market underwriting a decline scenario rather than a growth one.

The valuation X-ray is the mirror image of an expensive stock: every family lands above the price. The relative-multiple read is especially stark, reflecting how far below peer IT-services multiples Cognizant trades. The net-cash balance sheet, about $927 million of net cash and interest covered over 100 times, removes financial risk entirely, so the discount is not about solvency. It is entirely about the market's expectation that AI will erode the earnings base.

The synthesis is that this is a deep-value setup whose verdict turns on one question: is the IT-services earnings model durable or structurally impaired? If AI proves to be a tool services firms harness rather than a force that disintermediates them, the methods near $86 and the bullish analyst targets toward $77 to $88 are the relevant anchors, and the stock is meaningfully mispriced. If AI compresses the labor-arbitrage model, the low multiple is the market pricing a smaller future, and the $86 methods are anchored to earnings that will not persist. The cash-rich balance sheet means time is on the company's side, but the central debate is about the earnings base, not the balance sheet, and that is why a stock this statistically cheap carries a Hold consensus rather than a Buy.

Catalysts

The defining recent event was Q1 2026 results reported April 29, 2026: revenue up 5.8% to $5.413 billion in the upper half of guidance, adjusted EPS of $1.40, and bookings of $29.6 billion at a 1.4 book-to-bill ratio. Cognizant signed seven large deals with over 70% large-deal total contract value growth year over year, led by Financial Services, and reaffirmed full-year revenue growth of 4% to 6.5%. Alongside results, the company introduced Project Leap, a restructuring expected to generate $200 to $300 million of 2026 savings and to incur $230 to $320 million of mostly severance-related costs, which lifted 2026 adjusted operating margin guidance to 16.0% to 16.2%. The pace of large-deal signings and how cleanly Project Leap converts to margin are the two operating signals that matter most.

The overarching catalyst is the market's read on AI. The stock trades near multi-year-low multiples specifically on fears that generative AI will disrupt the IT-services model, so any evidence that Cognizant is winning AI-related work, rather than losing headcount-linked revenue, is a potential re-rating event, and its AI builder strategy and AI Forum are aimed squarely at that narrative. Analyst sentiment is split: Wedbush upgraded the stock to Outperform and raised its target, while Morgan Stanley cut its target to $44 at Equal Weight on AI concerns, leaving a Hold consensus with targets spanning roughly $51 to $100. Continued buybacks, funded by the net-cash balance sheet at a 6x multiple, are a steady support. The next earnings report, bookings durability, and any sign that AI is additive rather than dilutive to revenue are the events most likely to move the thesis.

Sources: Cognizant Q1 2026 results and Project Leap (StockTitan), Cognizant Q1 2026 8-K (SEC), Morgan Stanley cuts CTSH target (Insider Monkey), CTSH analyst ratings (Benzinga).

Peer Cohorts (Per Segment, With Filing Citations)

Health Sciences / Products and Resources / Communications, Media and Technology (reported)

Financial Services (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive CTSH report on boothcheck